Curative’s mission is to end the COVID-19 pandemic by providing simple-to-use and painless testing at scale to produce reliable data for patients and health officials. We know that broad access to testing, robust contact tracing, and a vaccine are necessary to end the pandemic.
Curative was founded in January 2020 with the initial aim of developing a new test for sepsis. The company pivoted to COVID-19 testing in early March 2020 as supply chains became strained and the need for a new testing process arose.
Since then we have successfully developed a COVID-19 test that uses an orthogonal supply chain to keep critical test materials readily available. Our team of doctors, scientists, engineers, and health industry experts continue to focus on making COVID-19 testing more accessible and pain-free as we scale to process 1 million tests per week.